Risk factors for disseminated intravascular coagulation in patients with lung cancer.
Kentaro NakanoKumiya SugiyamaHideyuki SatohSadaaki ShiromoriKei SugitateHajime ArifukuNaruo YoshidaHiroyoshi WatanabeShingo TokitaTomoshige WakayamaMasamitsu TatewakiRyosuke SoumaKenya KoyamaHirokuni HirataYasutsugu FukushimaPublished in: Thoracic cancer (2018)
Coagulation disorders may develop secondary to chronic inflammation in patients with progressive lung cancer. DIC in lung cancer may be attributed to changes in anticoagulation factors, such as thrombomodulin and antithrombin, but not in other coagulation factors.